ENAPRAZ-DSR
Composition
Esomeprazole 40mg + Domperidone 30mg Sustained Release Capsules
Indication
Esomeprazole combined with Domperidone (Enapraz DSR) forms a potent therapeutic combination used primarily in the management of gastroesophageal reflux disease (GERD) and functional dyspepsia. Enapraz DSR capsules, which contain enteric-coated esomeprazole (40mg) and sustained-release domperidone (30mg), are designed to provide effective relief from symptoms associated with these conditions.
Enapraz DSR capsules are beneficial for patients experiencing symptoms like heartburn, acid regurgitation, and upper abdominal discomfort. Esomeprazole, a proton pump inhibitor (PPI), reduces stomach acid production, aiding in the healing of erosive esophagitis and preventing its recurrence. Domperidone, a dopamine antagonist, enhances gastric emptying and reduces nausea and vomiting, improving symptoms related to gastric motility in functional dyspepsia.
Enapraz DSR capsules provide a dual-action approach that effectively addresses the underlying causes of GERD and helps alleviate discomfort associated with functional dyspepsia. This medication is designed to deliver comprehensive symptom relief when used as directed by healthcare professionals, ensuring optimal therapeutic outcomes and minimizing potential side effects.
Contraindication
Diarrhoea, Flatulence, Headache, Nausea, Vomiting, Constipation, Fundic gland polyps, abdominal pain.Storage
Cool & Dry PlaceDosage
As directed by a Medical Practitioner or Physician.
Inquire Now